Search

everythinglearnresearchcommunity

for

Search:↓

4-octyl itaconate may prevent hearing loss caused by the drug cisplatin by activating certain cell protection pathways.

Hair follicle transplantation speeds up wound healing in diabetic mice.

Hair loss condition FFA was seen before the appearance of skin depigmentation vitiligo in a patient.

Blocking LFA-1 prevents hair loss in mice.

Inflammation linked to the immune response may play a role in causing various types of hair loss.

Removing EGFR in skin causes inflammation and abnormal hair growth.

ILC1-like cells can independently cause alopecia areata.

High beta-hydroxybutyrate levels may worsen hair loss in alopecia areata.

Advancements in gene therapy, stem cells, and biomaterials show promise for reducing scarring in wound healing, but face clinical challenges.

Extracellular vesicles show promise for treating psoriasis by reducing inflammation and skin lesions.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Lung immune cells can be trained to better fight infections after a virus.

Standardized methods are needed to understand how process conditions affect extracellular vesicle protein content for skin therapy.

Acanthus ebracteatus Vahl. extract and verbascoside may help prevent hair loss and promote hair growth due to their anti-inflammatory properties and ability to protect against cell death.

Mice with alopecia areata had wider lymphatic vessels in their skin.

Ovalbumin–aluminum sensitization causes increased pain sensitivity and nerve changes in mice.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

TNFα helps grow and maintain liver cells in 3D culture for a long time.

Certain immune cells in the skin release a protein that stops hair growth by keeping hair stem cells inactive.

Future wound dressings will be smart, multifunctional, and improve personalized medicine.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

The model helps understand and improve treatments for alopecia areata by simulating hair growth and immune cell interactions.

Skin cells release substances important for healing and fighting infection, and understanding these could improve skin disorder treatments.

NIPP1 is important for healthy skin and could help treat skin inflammation.

Dandruff might be caused by changes in how hair follicles naturally release oils and an immune response to this imbalance.

BOOST is a promising, easy-to-use treatment for diabetic foot ulcers that improves healing by reducing inflammation and promoting blood vessel growth.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.